The company in question is, Catalent, Inc. (NYSE:CTLT) currently with a stock price of 23.44 (-1.22% today). The market cap for Catalent, Inc. is 2994.73, and is in the sector Healthcare, and Drugs – Generic industry. The target price for Catalent, Inc. is 27.4. Currently Catalent, Inc. is trading with a P/E of 26.75, and a forward P/E of 15.58. Average volume for Catalent, Inc. is 1190.82 and so far today it is 289577.
Performance in the last year for Catalent, Inc. has been -5.04%. For EPS growth, Catalent, Inc. has seen a growth of -49.30%, and is looking to grow in the next year to 10.68%. More long term stats show that EPS growth has been 38.80% over the last five years and could be 7.57% for the next five years. Catalent, Inc. has seen sales growth quarter over quarter at 4.30%, with EPS growth quarter over quarter at -59.50%. The 20-day simple moving average is -7.17%, with the 200-day simple moving average coming to -7.04%.
Since the IPO date for Catalent, Inc. on the 7/31/2014, Catalent, Inc. has seen performance year to date to be -5.19%. With Catalent, Inc. trading at 23.44, the dividend yield is *TBA, and the EPS is 0.89.
So could Catalent, Inc., be undervalued? Well as said before P/E is 26.75. The PEG is 3.54, P/S is 1.62 and the P/B is at 4.65. The P/cash is 22.76, with P/free cash flow at 190.75.
Catalent, Inc. ability to deal with debt shows that the current ratio is 2, and the quick ratio is 1.6. This is with long term debt/equity at 2.88, and total debt/equity at 2.93.
In terms of margins, Catalent, Inc. has a gross margin of 31.80%, an operating margin of 11.80% and a profit margin of 6.00%.Payout ratio for Catalent, Inc. is 0.00%. Return on assets come to 3.60% with return on investment coming to 7.40%.
Insider ownership for Catalent, Inc., is at 0.70% and institutional ownership comes to 75.90%. Outstanding shares are at 126.2. While shares float is 124.15. The float short is currently 3.75%, and short ratio is 3.91.